Nasdaq Biotechnology Ishares ETF (IBB)

$141.30 +1.07 (0.76%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 552,023
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Phone: 1-800-474-2737
WallStWingman
WallStWingman Oct. 3 at 8:42 PM
Biotech is sneaking a peek above the 2020 & 2022 pivot level, where price rejected in 2024 $IBB
1 · Reply
highnihilism
highnihilism Oct. 3 at 4:06 PM
$IBB iShares Biotechnology ETF Trades: 321 | Total $: 1.16 M | 1.55 × 90-Day Avg $: 745.6 K | Call $: 1.07 M | Put $: 83.9 K | Single-Leg: 30% | Multi-Leg: 32% | Contingent: 39% $EFA iShares MSCI Eafe ETF Trades: 1,398 | Total $: 2.61 M | 0.20 × 90-Day Avg $: 13.11 M | Call $: 1.07 M | Put $: 1.55 M | Single-Leg: 73% | Multi-Leg: 13% | Contingent: 14% $GEMI Gemini Space Station Trades: 1,154 | Total $: 1.2 M | 0.35 × 90-Day Avg $: 3.42 M | Call $: 1.06 M | Put $: 136.3 K | Single-Leg: 79% | Multi-Leg: 21% $ACI Albertsons Companies Trades: 1,455 | Total $: 1.09 M | 6.19 × 90-Day Avg $: 176.2 K | Call $: 1.06 M | Put $: 27.3 K | Single-Leg: 98% | Multi-Leg: 2%
0 · Reply
SGL_FGHI
SGL_FGHI Oct. 3 at 2:00 PM
$VKTX The BP patent cliffs are real. VKTX’s pipeline and associated TAM opportunities are real. Only question in my mind is which BP will realize first it’s best not to be penny-wise and pound-foolish. $XBI $IBB
0 · Reply
JFDI
JFDI Oct. 2 at 7:14 PM
$IBB
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 2 at 3:29 PM
$XLV from false moves come fast moves $XBI $IBB
0 · Reply
Quantumup
Quantumup Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated $AXGN at a Buy rating and a $24 price target. $XBI $IBB Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and $24 price target. Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry. Canaccord Genuity said in its notes to investors:
0 · Reply
QuantLake
QuantLake Oct. 2 at 10:15 AM
Biotech +2.87% Surge vs Momentum -0.21% Drop – Wednesday Performance Breakdown: Top 2 (by %): Biotech $IBB +2.87%, Bitcoin $IBIT +2.68% Bottom 2: Min Volatility $USMV -0.18%, Momentum $MTUM -0.21% What We See: $IBB: Bullish Momentum – Neutral Sentiment, steady within biotech growth positioning $IBIT: Neutral Momentum – Neutral Sentiment, reflects neutral tone in digital assets $USMV: Bullish Momentum – Neutral Sentiment, maintains role in risk-managed strategies $MTUM: Bullish Momentum – Positive Sentiment, anchors momentum-driven allocation
0 · Reply
SweepCastApp
SweepCastApp Oct. 2 at 6:15 AM
$IBB: Unusual Options Activity Alerted CALL flow observed 24x contracts at Strike price of $130 Exp on 10/17/2025 with Premium of $30K and showing BULLISH Sentiment
0 · Reply
theroyalflush
theroyalflush Oct. 1 at 8:19 PM
$IBB $LLY $PFE $QQQ $SPY
0 · Reply
theroyalflush
theroyalflush Oct. 1 at 8:19 PM
Pharma Alert! Keep an eye on the biosimilar market. Companies rapidly expanding their portfolios beyond immunology, like $ALVO, are showing massive revenue growth potential. Strategic partnerships for development and commercialization are mitigating risk and accelerating product launches into high-growth areas like ophthalmology and oncology. Check the charts! 📈 Here are some healthcare companies to keep and eye on: $IBB (iShares Nasdaq Biotechnology ETF - broad biotech exposure) $XLV (Health Care Select Sector SPDR Fund - broad healthcare sector) $MRNA (A popular, highly-discussed pharmaceutical/biotech name)
0 · Reply
Latest News on IBB
‘Fast Money' traders talk opportunities in health care stocks

Oct 1, 2025, 5:48 PM EDT - 2 days ago

‘Fast Money' traders talk opportunities in health care stocks

AMGN BIIB BMY LLY MRK MRNA PFE

Trump's Biotech Playbook Ignites $350 Billion Investment Blitz

Sep 9, 2025, 10:41 AM EDT - 25 days ago

Trump's Biotech Playbook Ignites $350 Billion Investment Blitz

XBI

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Sep 3, 2025, 3:32 PM EDT - 4 weeks ago

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

ARGX BBH BMRN CYTK XBI

BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH

Sep 1, 2025, 8:03 AM EDT - 4 weeks ago

BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH

Trump's deadline looms for Big Pharma companies facing new tariffs

Jul 16, 2025, 3:30 PM EDT - 2 months ago

Trump's deadline looms for Big Pharma companies facing new tariffs

XLV

Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

Jul 13, 2025, 7:01 AM EDT - 2 months ago

Heard on the Street: Why pharma stocks have outperformed the broader market since Trump threatened the industry with a 200% tariff

XLV

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

Jul 9, 2025, 11:09 AM EDT - 3 months ago

Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

CPER XBI

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

Jul 6, 2025, 11:12 AM EDT - 3 months ago

Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI

XBI

5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New Highs

Jul 5, 2025, 8:05 AM EDT - 3 months ago

5 Stocks I'm Buying As The 'Big Beautiful Bill' Pushes The Market To New Highs

ACHC AMH ARE CHAT COLD ELS FSLR

Fast Money: WTI, IBB, UBER, CAT

Jun 13, 2025, 6:20 PM EDT - 4 months ago

Fast Money: WTI, IBB, UBER, CAT

UBER CAT

Healthcare Sector Checkup As U.S. Looks To Change Regulations

May 30, 2025, 3:30 PM EDT - 4 months ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

AGNG ARKG BBC BBH BBP BIB BIS

IBB: Now Is The Time To Be Contrarian

May 29, 2025, 10:59 AM EDT - 4 months ago

IBB: Now Is The Time To Be Contrarian

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 4 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD ILMN NVS SDGR

Trump is right about drug prices. He's just going about it all wrong.

May 13, 2025, 1:43 PM EDT - 5 months ago

Trump is right about drug prices. He's just going about it all wrong.

XBI XLV

New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 5 months ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE GSK SRPT XBI

Trump Says Pharmaceutical Tariffs Coming in Near Future

Apr 14, 2025, 2:03 PM EDT - 6 months ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN AZN BMY GSK JNJ LLY

Sell into strength in pharma, says Mizuho's Jared Holz

Apr 11, 2025, 7:17 PM EDT - 6 months ago

Sell into strength in pharma, says Mizuho's Jared Holz

XBI

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Apr 11, 2025, 10:30 AM EDT - 6 months ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN AZN BMY GSK JNJ LLY

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Apr 11, 2025, 5:30 AM EDT - 6 months ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

XBI

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 6 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Explainer: Prescription drugs become a target in Trump's trade war

Apr 9, 2025, 2:27 PM EDT - 6 months ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN AZN BMY GSK JNJ LLY

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Apr 9, 2025, 1:06 PM EDT - 6 months ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN AZN BMY GSK JNJ LLY

Why drug stocks are no longer a safe haven from the stock market's turmoil

Apr 9, 2025, 11:49 AM EDT - 6 months ago

Why drug stocks are no longer a safe haven from the stock market's turmoil

ABBV AMGN BMY JNJ LLY MRK PFE

Invest In A New Biotech Bull Market With XBI And IBB

Mar 2, 2025, 8:33 AM EST - 7 months ago

Invest In A New Biotech Bull Market With XBI And IBB

XBI

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Feb 25, 2025, 11:06 AM EST - 7 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

XLV AGNG ARKG BBC BBH BBP BIB

How tariffs could impact pharma and early-stage healthcare investments

Feb 3, 2025, 6:43 PM EST - 8 months ago

How tariffs could impact pharma and early-stage healthcare investments

XLV

Biotech walks a 'tightrope' amid unclear funding, regulations

Jan 30, 2025, 7:06 PM EST - 8 months ago

Biotech walks a 'tightrope' amid unclear funding, regulations

DCTH ELVN

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

Jan 13, 2025, 6:10 PM EST - 9 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

iShares Biotechnology ETF: Playing Defense

Dec 10, 2024, 1:33 PM EST - 10 months ago

iShares Biotechnology ETF: Playing Defense

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

Nov 25, 2024, 6:44 PM EST - 11 months ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

HIMS LLY MRNA NVO PFE

Health care stocks jump on Trump's nominee for FDA head

Nov 25, 2024, 6:22 PM EST - 11 months ago

Health care stocks jump on Trump's nominee for FDA head

HIMS LFMD MRNA PFE

Final Trade: Euro, IBB, SMH, NEM

Nov 20, 2024, 6:21 PM EST - 11 months ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

Nov 15, 2024, 6:54 PM EST - 11 months ago

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

APLD CCJ WST

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14, 2024, 7:36 AM EDT - 1 year ago

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

Aug 30, 2024, 5:34 PM EDT - 1 year ago

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

GILD XBI

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

Aug 12, 2024, 4:25 PM EDT - 1 year ago

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

LLY XBI

Analyst is 'extremely bullish' on biopharma

Jul 30, 2024, 3:25 PM EDT - 1 year ago

Analyst is 'extremely bullish' on biopharma

MRK PFE

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28, 2024, 12:25 PM EDT - 1 year ago

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

XBI

For Biotech Stocks To Move Higher, This Must Move Lower

May 13, 2024, 9:00 AM EDT - 1 year ago

For Biotech Stocks To Move Higher, This Must Move Lower

XBI

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Apr 10, 2024, 9:27 AM EDT - 1 year ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW HRTS IHE

Biotech's Next Gold Rush: Weight-Loss Drugs

Apr 2, 2024, 4:56 PM EDT - 1 year ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO

Catch The Medical Breakthroughs With The IBB ETF

Mar 28, 2024, 2:01 AM EDT - 1 year ago

Catch The Medical Breakthroughs With The IBB ETF

IBB: Let It Rest

Mar 26, 2024, 4:46 AM EDT - 1 year ago

IBB: Let It Rest

Why Biotech Stocks May Be Ready For A Recovery

Mar 9, 2024, 3:59 AM EST - 1 year ago

Why Biotech Stocks May Be Ready For A Recovery

BBH XLV

Navigating the big run in biotech

Feb 15, 2024, 1:44 PM EST - 1 year ago

Navigating the big run in biotech

XBI

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

Feb 8, 2024, 7:34 AM EST - 1 year ago

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

XLV

Healthcare In 2024: Navigating The Biopharma Bull Run

Jan 17, 2024, 11:22 PM EST - 1 year ago

Healthcare In 2024: Navigating The Biopharma Bull Run

FHLC IYH PPH VHT XBI XLV

WallStWingman
WallStWingman Oct. 3 at 8:42 PM
Biotech is sneaking a peek above the 2020 & 2022 pivot level, where price rejected in 2024 $IBB
1 · Reply
highnihilism
highnihilism Oct. 3 at 4:06 PM
$IBB iShares Biotechnology ETF Trades: 321 | Total $: 1.16 M | 1.55 × 90-Day Avg $: 745.6 K | Call $: 1.07 M | Put $: 83.9 K | Single-Leg: 30% | Multi-Leg: 32% | Contingent: 39% $EFA iShares MSCI Eafe ETF Trades: 1,398 | Total $: 2.61 M | 0.20 × 90-Day Avg $: 13.11 M | Call $: 1.07 M | Put $: 1.55 M | Single-Leg: 73% | Multi-Leg: 13% | Contingent: 14% $GEMI Gemini Space Station Trades: 1,154 | Total $: 1.2 M | 0.35 × 90-Day Avg $: 3.42 M | Call $: 1.06 M | Put $: 136.3 K | Single-Leg: 79% | Multi-Leg: 21% $ACI Albertsons Companies Trades: 1,455 | Total $: 1.09 M | 6.19 × 90-Day Avg $: 176.2 K | Call $: 1.06 M | Put $: 27.3 K | Single-Leg: 98% | Multi-Leg: 2%
0 · Reply
SGL_FGHI
SGL_FGHI Oct. 3 at 2:00 PM
$VKTX The BP patent cliffs are real. VKTX’s pipeline and associated TAM opportunities are real. Only question in my mind is which BP will realize first it’s best not to be penny-wise and pound-foolish. $XBI $IBB
0 · Reply
JFDI
JFDI Oct. 2 at 7:14 PM
$IBB
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 2 at 3:29 PM
$XLV from false moves come fast moves $XBI $IBB
0 · Reply
Quantumup
Quantumup Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated $AXGN at a Buy rating and a $24 price target. $XBI $IBB Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and $24 price target. Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry. Canaccord Genuity said in its notes to investors:
0 · Reply
QuantLake
QuantLake Oct. 2 at 10:15 AM
Biotech +2.87% Surge vs Momentum -0.21% Drop – Wednesday Performance Breakdown: Top 2 (by %): Biotech $IBB +2.87%, Bitcoin $IBIT +2.68% Bottom 2: Min Volatility $USMV -0.18%, Momentum $MTUM -0.21% What We See: $IBB: Bullish Momentum – Neutral Sentiment, steady within biotech growth positioning $IBIT: Neutral Momentum – Neutral Sentiment, reflects neutral tone in digital assets $USMV: Bullish Momentum – Neutral Sentiment, maintains role in risk-managed strategies $MTUM: Bullish Momentum – Positive Sentiment, anchors momentum-driven allocation
0 · Reply
SweepCastApp
SweepCastApp Oct. 2 at 6:15 AM
$IBB: Unusual Options Activity Alerted CALL flow observed 24x contracts at Strike price of $130 Exp on 10/17/2025 with Premium of $30K and showing BULLISH Sentiment
0 · Reply
theroyalflush
theroyalflush Oct. 1 at 8:19 PM
$IBB $LLY $PFE $QQQ $SPY
0 · Reply
theroyalflush
theroyalflush Oct. 1 at 8:19 PM
Pharma Alert! Keep an eye on the biosimilar market. Companies rapidly expanding their portfolios beyond immunology, like $ALVO, are showing massive revenue growth potential. Strategic partnerships for development and commercialization are mitigating risk and accelerating product launches into high-growth areas like ophthalmology and oncology. Check the charts! 📈 Here are some healthcare companies to keep and eye on: $IBB (iShares Nasdaq Biotechnology ETF - broad biotech exposure) $XLV (Health Care Select Sector SPDR Fund - broad healthcare sector) $MRNA (A popular, highly-discussed pharmaceutical/biotech name)
0 · Reply
ASM
ASM Oct. 1 at 5:46 PM
omfg wow Trump sending pharma stonks through the ROOF after his 100% tariffs rolled out ALWAYS buy the tariff headlines within days he cut deals and carved exemptions and exploded them all KNEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEL $SPY $QQQ $PFE $LLY $IBB
0 · Reply
jjon2121
jjon2121 Oct. 1 at 2:33 PM
$LABD $LABU $XBI $IBB This is what I think is happening. Look at buyout activity. When this XBI run started. XBI dipped to 92.62 on 9/15. If you use that as the base. XBI hit 101.87 so far today. 102.62 would give it a $10 buyout boost. Buyouts- CSL 9/16 2.1B Roche 9/18 3.5B Pfizer 9/22 7.3B Genmab 9/29 8B That 8B buyout on 9/29 was a surprise & kept the run going instead of a pullback.
2 · Reply
WallStJesus
WallStJesus Oct. 1 at 2:06 PM
$IBB
0 · Reply
QuantLake
QuantLake Oct. 1 at 6:22 AM
Biotech +1.38% vs. Preferreds -0.52% – Tuesday Market Summary: Top 2 (by %): $IBB +1.38%, $SMH +1.15% Bottom 2: $IBIT +0.05%, $PFF -0.52% Our Data Points To: $IBB: Bullish Momentum – Neutral Sentiment, supports healthcare innovation exposure $SMH: Bullish Momentum – Positive Sentiment, anchors semiconductor sector allocation $IBIT: Neutral Momentum – Neutral Sentiment, reflects neutral crypto positioning $PFF: Bullish Momentum – Neutral Sentiment, suggests balanced preferred footing
0 · Reply
Thamb19
Thamb19 Oct. 1 at 1:32 AM
$BMRN $GNOM $BBH $IBB Biomarin calls indicate max pain can shift to $60 with a 15% upside. Check out max pain...
0 · Reply
Thamb19
Thamb19 Oct. 1 at 1:30 AM
$BMRN $BBH $IBB $GNOM Biomarin darkpool activity and algos bought and price held. Check my posts below.
0 · Reply
C_FC
C_FC Sep. 30 at 11:33 PM
$INAB $CAPR $PGEN $IBB $BTK
0 · Reply
C_FC
C_FC Sep. 30 at 7:37 PM
$INAB $CAPR $PGEN $IBB $BTK
0 · Reply
ASM
ASM Sep. 30 at 7:11 PM
Biotech SCREAMING endlessly what a trend $IBB $SPY $QQQ
0 · Reply
BioAmerica
BioAmerica Sep. 30 at 12:54 PM
$XBI $IBB Man, I know it is a totally different sector, but did the shorts get there a$$ handed to them on that $WOLF deal yesterday or what? Some biotechs should take note of the way it was done. The shorts in this sector need to be taught a similar lesson.
0 · Reply
highnihilism
highnihilism Sep. 30 at 7:50 AM
$ITW Illinois Tool Works: 85 trades, $314K vs $216K avg (1.46x). $280K calls / $35K puts. 95% single-leg. $ROST Ross Stores: 342 trades, $431K vs $1.74M avg (0.25x). $279K calls / $152K puts. 88% single-leg. $USD ProShares Ultra Semiconductors: 123 trades, $357K vs $409K avg (0.87x). $278K calls / $79K puts. 78% single-leg. $IBB iShares Biotechnology ETF: 164 trades, $393K vs $813K avg (0.48x). $276K calls / $117K puts. 77% single-leg.
0 · Reply
SenefAS
SenefAS Sep. 29 at 9:15 AM
Monday buyout $GMAB GENMAB TO ACQUIRE $MRUS MERUS FOR $97 PER SHARE IN AN ALL-CASH TRANSACTION VALUED AT $8 BILLION #biotech $XBI $IBB
1 · Reply